In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Artelo Biosciences (ARTL – Research
In a report released yesterday, Mani Foroohar from Leerink Partners reiterated a Buy rating on Mirum Pharmaceuticals (MIRM – Research
Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Vincera Pharma (VINC – Research Report) today and set a
Raymond James analyst Steven Seedhouse maintained a Hold rating on Gilead Sciences (GILD – Research Report) yesterday. The company’s shares
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report)
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on AngioDynamics (ANGO – Research Report).
In a report released today, Robert Dodd from Raymond James maintained a Buy rating on Fortress Transportation (FTAI – Research